D
Dorota Kendler
Researcher at Innsbruck Medical University
Publications - 34
Citations - 3327
Dorota Kendler is an academic researcher from Innsbruck Medical University. The author has contributed to research in topics: Neuroendocrine tumors & Radionuclide therapy. The author has an hindex of 20, co-authored 34 publications receiving 3001 citations. Previous affiliations of Dorota Kendler include University of Innsbruck.
Papers
More filters
Journal ArticleDOI
68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT
Michael Gabriel,Clemens Decristoforo,Dorota Kendler,Georg Dobrozemsky,Dirk Heute,Christian Uprimny,Peter Kovacs,Elisabeth von Guggenberg,Reto Bale,Irene Virgolini +9 more
TL;DR: 68Ga-DOTA-TOC PET shows a significantly higher detection rate compared with conventional somatostatin receptor scintigraphy and diagnostic CT with clinical impact in a considerable number of patients and showed higher diagnostic efficacy compared with SPECT.
Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT
Michael Gabriel,Clemens Decristoforo,Dorota Kendler,Georg Dobrozemsky,Dirk Heute,Christian Uprimny,Peter Kovacs,Elisabeth von Guggenberg,Reto Bale,Irene Virgolini +9 more
TL;DR: In this article, the authors compared the performance of PET and CT in patients with known or suspected neuroendocrine tumors and found that PET showed higher diagnostic efficacy compared with SPECT and CT.
Journal ArticleDOI
68 Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate?
Francesco Ceci,Francesco Ceci,Christian Uprimny,Bernhard Nilica,Llanos Geraldo,Dorota Kendler,Alexander Kroiss,Jasmin Bektic,Wolfgang Horninger,Peter Lukas,Clemens Decristoforo,Paolo Castellucci,Stefano Fanti,Irene Virgolini +13 more
TL;DR: The great potential of 68Ga-PSMA PET/CT in patients with rPCa and BR was confirmed and PSA and PSAdt were valuable predictors of pathological 68Ga/CT findings.
Journal ArticleDOI
68 Ga-PSMA-11 PET/CT in primary staging of prostate cancer: PSA and Gleason score predict the intensity of tracer accumulation in the primary tumour
Christian Uprimny,Alexander Kroiss,Clemens Decristoforo,Josef Fritz,Elisabeth von Guggenberg,Dorota Kendler,Lorenza Scarpa,Gianpaolo di Santo,Llanos Geraldo Roig,Johanna Maffey-Steffan,Wolfgang Horninger,Irene Virgolini +11 more
TL;DR: The GS and PSA level correlated with the intensity of tracer accumulation in the primary tumours of PC patients on 68Ga-PSMA-11 PET/CT, which should be preferentially applied for primary staging of PC in patients with GS >7 or PSA levels ≥10 ng/ml.
Journal ArticleDOI
Bone Metastases in Patients with Neuroendocrine Tumor: 68Ga-DOTA-Tyr3-Octreotide PET in Comparison to CT and Bone Scintigraphy
Daniel Putzer,Michael Gabriel,Benjamin Henninger,Dorota Kendler,Christian Uprimny,Georg Dobrozemsky,Clemens Decristoforo,Reto Bale,Werner Jaschke,Irene Virgolini +9 more
TL;DR: In this article, the authors compared the diagnostic value of CT with that of the novel somatostatin analog 68Ga-1,4,7,10-tetraazacyclodododecane-N,N′,N″, N′′′-Tetraacetic acid-d-Phe1-Tyr3-Octreotide (68Ga-DOTATOC) in the detection of such metastases.